MAZE Earnings Maze Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–9 of 9
| Q1 2026 | 2026-03-31 | -0.45 | 2026-05-12 | 10-Q |
| FY 2025 | 2025-12-31 | -3.05 | 2026-03-25 | 10-K |
| Q3 2025 | 2025-09-30 | -2.45 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.83 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.15 | 2026-05-12 | 10-Q |
| FY 2025 | 2024-12-31 | 1.25 | 2026-03-25 | 10-K |
| Q3 2025 | 2024-09-30 | 2.67 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | 3.18 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -13.91 | 2025-05-14 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.